Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 24.41% is in line with its 5-year average of 22.85%, near the high end of its 5-year range (15.34%–26.50%).
As of the fiscal period ended Tuesday, March 31, 2026. 0.63% below its 12-month average of 24.56%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
24.41%
NET PROFIT MARGIN AVG TTM
24.56%
NET PROFIT MARGIN AVG 3Y
23.84%
NET PROFIT MARGIN AVG 5Y
23.23%
NET PROFIT MARGIN AVG 10Y
19.71%
NET PROFIT MARGIN AVG 15Y
17.49%
NET PROFIT MARGIN AVG 20Y
16.07%
CURRENT VS TTM AVG
-0.63%
CURRENT VS 3Y AVG
+2.39%
CURRENT VS 5Y AVG
+5.09%
CURRENT VS 10Y AVG
+23.84%
CURRENT VS 15Y AVG
+39.51%
CURRENT VS 20Y AVG
+51.85%
SECTOR MEDIAN · HEALTHCARE
10.44%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+133.79%
vs the sector median at left
IDEXX Laboratories, Inc.
Market Cap
$42.94B
Net Profit Margin
24.41%
TTM Avg
24.56%
3Y Avg
23.84%
5Y Avg
23.23%
Market Cap
$39.14B
Net Profit Margin
19.55%
TTM Avg
19.27%
3Y Avg
18.75%
5Y Avg
17.94%
Market Cap
$47.58B
Net Profit Margin
17.34%
TTM Avg
47.22%
3Y Avg
37.68%
5Y Avg
33.03%
Market Cap
$36.28B
Net Profit Margin
13.46%
TTM Avg
-1.96%
3Y Avg
-34.26%
5Y Avg
-68.70%
Market Cap
$34.72B
Net Profit Margin
8.33%
TTM Avg
8.63%
3Y Avg
8.47%
5Y Avg
7.22%
Market Cap
$53.41B
Net Profit Margin
0.62%
TTM Avg
0.54%
3Y Avg
0.18%
5Y Avg
-0.22%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $42.94B | 24.41% | 24.56% | 23.84% | 23.23% |
| Agilent Technologies, Inc. (A)vs › | $39.14B | 19.55% | 19.27% | 18.75% | 17.94% |
| Humana Inc. (HUM)vs › | $46.74B | 0.82% | 0.97% | 1.82% | 2.53% |
| Edwards Lifesciences Corporation (EW)vs › | $47.58B | 17.34% | 47.22% | 37.68% | 33.03% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 13.46% | -1.96% | -34.26% | -68.70% |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 8.33% | 8.63% | 8.47% | 7.22% |
| Medline Inc. (MDLN)vs › | $32.77B | 3.31% | 4.39% | 2.42% | 2.42% |
| Cardinal Health, Inc. (CAH)vs › | $53.41B | 0.62% | 0.54% | 0.18% | -0.22% |
| Zoetis Inc. (ZTS)vs › | $31.59B | 27.79% | 27.55% | 27.17% | 26.57% |
| Centene Corp. (CNC)vs › | $31.31B | -3.25% | -0.70% | 0.29% | 0.65% |
Operating Margin
31.6%
Net Profit Margin
24.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 24.41% |
| 2025-12-31 | 22.76% |
| 2025-09-30 | 24.85% |
| 2025-06-30 | 26.50% |
| 2025-03-31 | 24.31% |
| 2024-12-31 | 22.65% |
| 2024-09-30 | 23.87% |
| 2024-06-30 | 20.26% |
| 2024-03-31 | 24.44% |
| 2023-12-31 | 21.58% |
| 2023-09-30 | 23.18% |
| 2023-06-30 | 23.76% |
| 2023-03-31 | 23.78% |
| 2022-12-31 | 20.78% |
| 2022-09-30 | 21.50% |
| 2022-06-30 | 15.34% |
| 2022-03-31 | 23.19% |
| 2021-12-31 | 20.32% |
| 2021-09-30 | 21.62% |
| 2021-06-30 | 24.52% |
| 2021-03-31 | 26.26% |
| 2020-12-31 | 24.24% |
| 2020-09-30 | 20.26% |
| 2020-06-30 | 23.36% |
| 2020-03-31 | 17.85% |
| 2019-12-31 | 14.95% |
| 2019-09-30 | 17.98% |
| 2019-06-30 | 20.27% |
| 2019-03-31 | 17.82% |
| 2018-12-31 | 15.59% |
| 2018-09-30 | 17.10% |
| 2018-06-30 | 18.72% |
| 2018-03-31 | 16.64% |
| 2017-12-31 | 7.56% |
| 2017-09-30 | 14.33% |
| 2017-06-30 | 16.77% |
| 2017-03-31 | 14.94% |
| 2016-12-31 | 11.82% |
| 2016-09-30 | 12.59% |
| 2016-06-30 | 14.40% |
| 2016-03-31 | 11.02% |
| 2015-12-31 | 11.10% |
| 2015-09-30 | 10.88% |
| 2015-06-30 | 13.77% |
| 2015-03-31 | 12.18% |
| 2014-12-31 | 7.38% |
| 2014-09-30 | 13.60% |
| 2014-06-30 | 14.67% |
| 2014-03-31 | 12.93% |
| 2013-12-31 | 12.22% |
| 2013-09-30 | 13.51% |
| 2013-06-30 | 15.31% |
| 2013-03-31 | 13.51% |
| 2012-12-31 | 13.57% |
| 2012-09-30 | 13.58% |
| 2012-06-30 | 15.29% |
| 2012-03-31 | 12.63% |
| 2011-12-31 | 12.37% |
| 2011-09-30 | 12.79% |
| 2011-06-30 | 15.31% |
| 2011-03-31 | 12.51% |
| 2010-12-31 | 12.82% |
| 2010-09-30 | 12.87% |
| 2010-06-30 | 13.21% |
| 2010-03-31 | 12.30% |
| 2009-12-31 | 11.45% |
| 2009-09-30 | 12.17% |
| 2009-06-30 | 12.67% |
| 2009-03-31 | 11.03% |
| 2008-12-31 | 9.68% |
| 2008-09-30 | 10.23% |
| 2008-06-30 | 14.03% |
| 2008-03-31 | 11.06% |
| 2007-12-31 | 10.42% |
| 2007-09-30 | 11.25% |
| 2007-06-30 | 9.14% |
| 2007-03-31 | 9.96% |
| 2006-12-31 | 12.84% |
| 2006-09-30 | 13.32% |
| 2006-06-30 | 13.47% |
| 2006-03-31 | 10.87% |
| 2005-12-31 | 11.99% |
| 2005-09-30 | 13.03% |
| 2005-06-30 | 12.41% |
| 2005-03-31 | 11.61% |
| 2004-12-31 | 11.74% |
| 2004-09-30 | 14.69% |
| 2004-06-30 | 17.40% |
| 2004-03-31 | 13.33% |
| 2003-12-31 | 9.90% |
| 2003-09-30 | 13.30% |
| 2003-06-30 | 13.70% |
| 2003-03-31 | 11.04% |
| 2002-12-31 | 12.05% |
| 2002-09-30 | 11.94% |
| 2002-06-30 | 12.27% |
